Beyond Air, Inc.

Introduction

This page provides a comprehensive analysis of the known insider trading history of Lisi Steven A.. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

See Highest Ranking Insiders
Companies with Reported Insider Positions

The SEC filings indicate Lisi Steven A. has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:XAIR / Beyond Air, Inc. CEO and Chairman of the Board, Director 3,327,411
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Lisi Steven A.. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases XAIR / Beyond Air, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in XAIR / Beyond Air, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Max		 Price at
Max		 Max
Profit ($)		 Max Return (%)
2025-07-21 XAIR Lisi Steven A. 6,000 3.2485 6,000 3.2485 19,491 1 3.4000 909 4.66
2024-09-26 XAIR Lisi Steven A. 1,476,626 0.5043 73,831 10.0860 744,662
2024-08-15 XAIR Lisi Steven A. 50,000 0.3668 2,500 7.3360 18,340
2024-08-14 XAIR Lisi Steven A. 100,000 0.3864 5,000 7.7280 38,640
2023-12-18 XAIR Lisi Steven A. 77,775 1.6303 3,889 32.6060 126,797
2023-03-17 XAIR Lisi Steven A. 10,000 6.4600 500 129.2000 64,600
2023-03-08 XAIR Lisi Steven A. 5,000 5.8870 250 117.7400 29,435
2023-03-07 XAIR Lisi Steven A. 45,000 5.9760 2,250 119.5200 268,920
2022-06-30 XAIR Lisi Steven A. 73,000 6.6260 3,650 132.5200 483,698
2021-12-10 XAIR Lisi Steven A. 40,000 8.5300 2,000 170.6000 341,200
2021-08-13 XAIR Lisi Steven A. 25,000 7.8500 1,250 157.0000 196,250
2021-06-17 XAIR Lisi Steven A. 25,000 5.3600 1,250 107.2000 134,000
2020-12-31 XAIR Lisi Steven A. 38,500 5.2800 1,925 105.6000 203,280
2020-08-14 XAIR Lisi Steven A. 20,000 5.5470 1,000 110.9400 110,940
2020-06-25 XAIR Lisi Steven A. 35,000 7.4500 1,750 149.0000 260,750
2019-12-12 XAIR Lisi Steven A. 190,437 3.6600 9,522 73.2000 696,999
2019-11-15 XAIR Lisi Steven A. 10,000 4.0873 500 81.7460 40,873
2019-11-14 XAIR Lisi Steven A. 10,000 4.0440 500 80.8800 40,440
2019-11-13 XAIR Lisi Steven A. 12,000 4.0900 600 81.8000 49,080
2019-11-12 XAIR Lisi Steven A. 8,000 4.0700 400 81.4000 32,560
2019-11-11 XAIR Lisi Steven A. 10,000 4.1900 500 83.8000 41,900
2019-06-03 XAIR Lisi Steven A. 58,253 5.1500 2,913 103.0000 300,003

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

XAIR / Beyond Air, Inc. Insider Trades
Insider Sales XAIR / Beyond Air, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in XAIR / Beyond Air, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Min		 Price at
Min		 Max Loss
Avoided ($)		 Max Loss
Avoided (%)
2023-02-16 XAIR Lisi Steven A. 48,596 6.1000 2,430 122.0000 296,436 337 1.3050 -293,265 -98.93
2021-12-29 XAIR Lisi Steven A. 21,376 9.5320 1,069 190.6400 203,756
2021-02-10 XAIR Lisi Steven A. 70,388 7.0713 3,519 141.4260 497,735
2019-12-30 XAIR Lisi Steven A. 5,992 4.4318 300 88.6360 26,555

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

XAIR / Beyond Air, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Lisi Steven A. as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change		 Share
Price		 Tran
Value		 Remaining
Value
2025-07-23 2025-07-21 4 XAIR Beyond Air, Inc.
Common Stock 		P - Purchase 6,000 3,327,411 0.18 3.25 19,491 10,809,095
2024-10-01 2024-09-26 4 XAIR Beyond Air, Inc.
Common Stock 		P - Purchase 1,476,626 3,249,411 83.29 0.50 744,662 1,638,678
2024-08-19 2024-08-15 4 XAIR Beyond Air, Inc.
Common Stock 		P - Purchase 50,000 1,772,785 2.90 0.37 18,340 650,258
2024-08-15 2024-08-14 4 XAIR Beyond Air, Inc.
Common Stock 		P - Purchase 100,000 1,722,785 6.16 0.39 38,640 665,684
2024-03-21 2024-03-20 4 XAIR Beyond Air, Inc.
Common Stock 		A - Award 78,314 1,614,785 5.10 1.66 130,001 2,680,543
2023-12-19 2023-12-18 4 XAIR Beyond Air, Inc.
Common Stock 		P - Purchase 77,775 1,536,471 5.33 1.63 126,797 2,504,909
2023-03-21 2023-03-17 4 XAIR Beyond Air, Inc.
Common Stock 		P - Purchase 10,000 1,458,696 0.69 6.46 64,600 9,423,176
2023-03-09 2023-03-08 4 XAIR Beyond Air, Inc.
Common Stock 		P - Purchase 5,000 1,447,849 0.35 5.89 29,435 8,523,487
2023-03-09 2023-03-07 4 XAIR Beyond Air, Inc.
Common Stock 		P - Purchase 45,000 1,442,849 3.22 5.98 268,920 8,622,466
2023-02-17 2023-02-16 4 XAIR Beyond Air, Inc.
Common Stock 		S - Sale -48,596 1,397,849 -3.36 6.10 -296,436 8,526,879
2022-07-05 2022-06-30 4 XAIR Beyond Air, Inc.
Common Stock 		P - Purchase 73,000 1,446,445 5.32 6.63 483,698 9,584,145
2022-03-07 2022-03-03 4 XAIR Beyond Air, Inc.
Stock Option (right to buy) 		A - Award 280,000 280,000
2022-03-07 2022-03-03 4 XAIR Beyond Air, Inc.
Common Stock 		A - Award 140,000 1,373,445 11.35
2022-01-14 2022-01-12 4 XAIR Beyond Air, Inc.
Warrants (right to buy) 		M - Exercise -83,334 0 -100.00
2022-01-14 2022-01-12 4 XAIR Beyond Air, Inc.
Common Stock 		M - Exercise 83,334 1,233,445 7.25 3.66 305,002 4,514,409
2022-01-03 2021-12-29 4 XAIR Beyond Air, Inc.
Common Stock 		S - Sale -21,376 1,150,111 -1.82 9.53 -203,756 10,962,858
2021-12-13 2021-12-10 4 XAIR Beyond Air, Inc.
Common Stock 		P - Purchase 40,000 1,171,487 3.54 8.53 341,200 9,992,784
2021-10-07 2021-10-05 4 XAIR Beyond Air, Inc.
Common Stock 		A - Award 100,000 1,131,487 9.69
2021-08-17 2021-08-13 4 XAIR Beyond Air, Inc.
Common Stock 		P - Purchase 25,000 1,031,487 2.48 7.85 196,250 8,097,173
2021-06-21 2021-06-17 4 XAIR Beyond Air, Inc.
Common Stock 		P - Purchase 25,000 1,006,487 2.55 5.36 134,000 5,394,770
2021-03-08 2021-03-04 4 XAIR Beyond Air, Inc.
Stock Option (right to buy) 		A - Award 200,000 200,000
2021-03-03 2021-02-10 4/A XAIR Beyond Air, Inc.
Common Stock 		F - Taxes -70,388 981,487 -6.69 7.07 -497,735 6,940,389
2021-03-03 2021-02-10 4/A XAIR Beyond Air, Inc.
Common Stock 		M - Exercise 117,112 1,051,875 12.53 4.25 497,726 4,470,469
2021-02-12 2021-02-10 4 XAIR Beyond Air, Inc.
Tranche B Warrant (right to buy) 		X - Other -117,112 0 -100.00
2021-02-12 2021-02-10 4 XAIR Beyond Air, Inc.
Common Stock 		S - Sale -70,388 981,487 -6.69 7.07 -497,735 6,940,389
2021-02-12 2021-02-10 4 XAIR Beyond Air, Inc.
Common Stock 		X - Other 117,112 1,051,875 12.53 4.25 497,726 4,470,469
2021-01-06 2021-01-04 4 XAIR Beyond Air, Inc.
Common Stock 		A - Award 5,500 934,763 0.59
2020-12-31 2020-12-31 4 XAIR Beyond Air, Inc.
Common Stock 		P - Purchase 38,500 929 -102.47 5.28 203,280 4,907
2020-08-18 2020-08-14 4 XAIR Beyond Air, Inc.
Common Stock 		P - Purchase 20,000 890,763 2.30 5.55 110,940 4,941,062
2020-06-29 2020-06-25 4 XAIR Beyond Air, Inc.
Common Stock 		P - Purchase 35,000 870,763 4.19 7.45 260,750 6,487,184
2019-12-31 2019-12-30 4 XAIR Beyond Air, Inc.
Common Stock 		S - Sale -5,992 815,763 -0.73 4.43 -26,555 3,615,298
2019-12-16 2019-12-12 4 XAIR Beyond Air, Inc.
Common Stock 		P - Purchase 190,437 821,755 30.16 3.66 696,999 3,007,623
2019-11-18 2019-11-15 4 XAIR Beyond Air, Inc.
Common Stock 		P - Purchase 10,000 631,318 1.61 4.09 40,873 2,580,386
2019-11-18 2019-11-14 4 XAIR Beyond Air, Inc.
Common Stock 		P - Purchase 10,000 621,318 1.64 4.04 40,440 2,512,610
2019-11-14 2019-11-13 4 XAIR Beyond Air, Inc.
Common Stock 		P - Purchase 12,000 611,318 2.00 4.09 49,080 2,500,291
2019-11-14 2019-11-12 4 XAIR Beyond Air, Inc.
Common Stock 		P - Purchase 8,000 599,318 1.35 4.07 32,560 2,439,224
2019-11-14 2019-11-11 4 XAIR Beyond Air, Inc.
Common Stock 		P - Purchase 10,000 591,318 1.72 4.19 41,900 2,477,622
2019-11-14 2019-06-03 4 XAIR Beyond Air, Inc.
Common Stock 		P - Purchase 58,253 581,318 11.14 5.15 300,003 2,993,788
2019-02-25 2019-01-01 4 AITB AIT Therapeutics, Inc.
Common Stock 		A - Award 12,000 464,286 2.65
2019-02-25 2018-12-31 4 AITB AIT Therapeutics, Inc.
Common Stock 		A - Award 88,000 452,286 24.16
2018-08-15 2018-08-13 4 AITB AIT Therapeutics, Inc.
Stock Option (right to buy) 		A - Award 400,000 400,000
2018-04-26 2018-02-16 4 AITB AIT Therapeutics, Inc.
Tranche A Warrant (right to buy) 		M - Exercise -117,112 0 -100.00
2018-04-26 2018-02-16 4 AITB AIT Therapeutics, Inc.
Tranche A Warrant (right to buy) 		P - Purchase 117,112 117,112 0.01 1,171 1,171
2018-04-26 2018-02-16 4 AITB AIT Therapeutics, Inc.
Tranche A Warrant (right to buy) 		P - Purchase 117,112 117,112 0.01 1,171 1,171
2018-04-26 2018-02-16 4 AITB AIT Therapeutics, Inc.
Common Stock 		M - Exercise 117,112 523,065 28.85 4.25 497,726 2,223,026
2017-06-07 3 AITB AIT Therapeutics, Inc.
Common Stock 		811,906
2017-06-07 3 AITB AIT Therapeutics, Inc.
Common Stock 		811,906
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)